Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) seeks applications for a research center grant to conduct cross-cutting research on alcohol and HIV/AIDS. Through this FOA, NIAAA seeks to encourage research applications aimed to address the impact of alcohol use on the most important challenges for ending HIV/AIDS pandemic, outlined as the high priority topics of research by the NIH Office of AIDS Research ( In particular, bench-to-bedside translational studies of alcohol use as a risk factor impacting HIV prevention, latency, treatment effectiveness, and HIV-related comorbidities are strongly encouraged.


  • Letter of Intent Due Date(s): March 16, 2019
  • AIDS Application Due Date(s): April 16, 2019

RFA-AA-19-003 Expiration Date April 17, 2019

Agency Website

Eligibility Requirements

 This FOA supports linked applications. Multiple PDs/PIs are allowed on any single application. Because the FOA already supports a team approach between groups of experts across sites and collaborating applications, the designation of multiple PDs/PIs on a single application may be less likely to apply. PD(s)/PI(s) from each linked application should not be designated as multiple PDs/PIs on each application of a collaborative set.

The PD(s)/PI(s) of at least 1 of the collaborative application(s) must be a currently NIAAA funded PD(s)/PI(s) with established alcohol research programs. The PD(s)/PI(s) of at least 1 of the collaborative application(s) must be have with expertise in HIV/AIDS but may or may not be currently funded by NIAAA.



Amount Description

The application may not exceed $1.2 million direct costs per year.  

 The maximum project period is 5 years 

    Funding Type





    Medical - Basic Science
    Medical - Clinical Science
    Medical - Translational
    Social Sciences

    External Deadline

    April 16, 2019